Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Nirogyone Therapeutics LLC
Profile last edited on: 9/21/22      CAGE: 733J9      UEI: RJKNHNE4JKJ5

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2014
First Award
2017
Latest Award
2021
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

10 Laurel Avenue
Northborough, MA 01532
   (508) 439-2197
   N/A
   www.nirogyone.com
Location: Single
Congr. District: 02
County: Worcester

Public Profile

Currently in stealth mode, the two senior payers with the firm bring to the table extensive professional experience with major phamaceutical players.

Extent of SBIR involvement

User Avatar
Phase I Awards
3
Phase II Awards
1
Conversion Rate
33.33%
Phase I Dollars
$1,737,680
Phase II Dollars
$1,054,530
Total Awarded
$2,792,210

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2021 2 NIH $2,000,000
Project Title: Development of Tumor and Immuno-Metabolism Based Small Molecule Therapeutics for Refractory Breast Cancer
2019 1 NIH $292,210
Project Title: Tumor and Immuno-Metabolism Based Lactate Transporter Inhibitors for Metastatic Melanoma
2018 1 NIH $500,000
Project Title: Inhibitors of Cellular Transporters for the Treatment of TNBC

Key People / Management

  Vincent Sandanayaka -- Founder, President and CSO

  Jaime Escobedo -- Co-Founder

  Thomas Seng-Lai

Company News

There are no news available.